keyword
https://read.qxmd.com/read/38598877/an-evaluation-of-treatment-response-and-remission-definitions-in-adult-obsessive-compulsive-disorder-a-systematic-review-and-individual-patient-data-meta-analysis
#21
JOURNAL ARTICLE
Divya Ramakrishnan, Luis C Farhat, Edoardo F Q Vattimo, Jessica L S Levine, Jessica A Johnson, Bekir B Artukoglu, Angeli Landeros-Weisenberger, Abraham Zangen, Antoine Pelissolo, Carlos A de B Pereira, Christian Rück, Daniel L C Costa, David Mataix-Cols, David Shannahoff-Khalsa, David F Tolin, Elham Zarean, Elisabeth Meyer, Emily R Hawken, Eric A Storch, Erik Andersson, Euripedes C Miguel, Giuseppe Maina, James F Leckman, Jerome Sarris, John S March, Juliana B Diniz, Kenneth Kobak, Luc Mallet, Nienke C C Vulink, Revital Amiaz, Rodrigo Yacubian Fernandes, Roseli G Shavitt, Sabine Wilhelm, Shahrokh Golshan, Sophie Tezenas du Montcel, Stefano Erzegovesi, Upasana Baruah, William M Greenberg, Yuki Kobayashi, Michael H Bloch
INTRODUCTION: Expert consensus operationalized treatment response and remission in obsessive-compulsive disorder (OCD) as a Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) reduction ≥35% and score ≤12 with ≤2 on Clinical Global Impressions Improvement (CGI-I) and Severity (CGI-S) scales, respectively. However, there has been scant empirical evidence supporting these definitions. METHODS: We conducted a systematic review and an individual participant data meta-analysis of randomized-controlled trials (RCTs) in adults with OCD to determine optimal Y-BOCS thresholds for response and remission...
March 29, 2024: Journal of Psychiatric Research
https://read.qxmd.com/read/38598109/diminished-differentiation-of-rewards-in-individuals-at-clinical-high-risk-for-psychosis
#22
JOURNAL ARTICLE
D N Pratt, M T Treadway, G P Strauss, V A Mittal
Reward processing is impaired in people with schizophrenia, which may begin in the clinical high-risk (CHR) for psychosis period. The Monetary Incentive Delay (MID) task has been important in understanding the neural correlates of reward processing deficits in various psychiatric disorders. Previous research has found that CHR individuals have an imprecise mental representation of rewards, which leads to a diminished differentiation between rewards, though this has not been observed behaviorally. A total of 19 CHR individuals and 20 controls were given a novel variant of the MID task, designed to examine how modulating reward context may impact responses to reward cues, a process often referred to as "adaptive coding...
April 10, 2024: European Archives of Psychiatry and Clinical Neuroscience
https://read.qxmd.com/read/38588753/gut-brain-axis-in-the-pathogenesis-of-sepsis-associated-encephalopathy
#23
REVIEW
Xin Wang, Xiaoyue Wen, Shiying Yuan, Jiancheng Zhang
The gut-brain axis is a bidirectional communication network linking the gut and the brain, overseeing digestive functions, emotional responses, body immunity, brain development, and overall health. Substantial research highlights a connection between disruptions of the gut-brain axis and various psychiatric and neurological conditions, including depression and Alzheimer's disease. Given the impact of the gut-brain axis on behavior, cognition, and brain diseases, some studies have started to pay attention to the role of the axis in sepsis-associated encephalopathy (SAE), where cognitive impairment is the primary manifestation...
April 6, 2024: Neurobiology of Disease
https://read.qxmd.com/read/38586892/bodily-maps-of-symptoms-and-emotions-in-parkinson-s-disease
#24
JOURNAL ARTICLE
Kalle J Niemi, Annu Huovinen, Elina Jaakkola, Enrico Glerean, Lauri Nummenmaa, Juho Joutsa
BACKGROUND: Emotions are reflected in bodily sensations, and these reflections are abnormal in psychiatric conditions. However, emotion-related bodily sensations have not been studied in neurological disorders. OBJECTIVE: The aim of this study was to investigate whether Parkinson's disease (PD) is associated with altered bodily representations of emotions. METHODS: Symptoms and emotion-related sensations were investigated in 380 patients with PD and 79 control subjects, using a topographical self-report method, termed body sensation mapping...
April 8, 2024: Movement Disorders: Official Journal of the Movement Disorder Society
https://read.qxmd.com/read/38585552/detecting-a-novel-notch3-variant-in-patients-with-suspected-cadasil-a-single-center-study
#25
JOURNAL ARTICLE
Zeynep Selcan Şanli, Özlem Anlaş
INTRODUCTION: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common form of familial cerebral small vessel disease in adults and is caused by NOTCH3 variants. Clinical manifestations of CADASIL include recurrent ischemic strokes, dementia, migraine or migraineous headaches, epileptic seizures, and psychiatric disorders. The clinical-radiological phenotype of the disease is also highly variable. In this study, we investigated the variability of clinical, radiological, and genetic data in patients analyzed for NOTCH3 variant in our clinic...
March 2024: Molecular Syndromology
https://read.qxmd.com/read/38579621/structure-based-discovery-of-small-molecule-inhibitors-of-fkbp51-hsp90-protein-protein-interaction
#26
JOURNAL ARTICLE
Lisha Wang, Rajnish Kumar, Bengt Winblad, Pavel F Pavlov
The heat shock protein 90 kDa (Hsp90) molecular chaperone machinery is responsible for the folding and activation of hundreds of important clients such as kinases, steroid hormone receptors, transcription factors, etc. This process is dynamically regulated in an ATP-dependent manner by Hsp90 co-chaperones including a group of tetratricopeptide (TPR) motif proteins that bind to the C-terminus of Hsp90. Among these TPR containing co-chaperones, FK506-binding protein 51 kDa (FKBP51) is reported to play an important role in stress-related pathologies, psychiatric disorders, Alzheimer's disease, and cancer, making FKBP51-Hsp90 interaction a potential therapeutic target...
March 28, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38577629/ivr-fnirs-studying-brain-functions-in-a-fully-immersive-virtual-environment
#27
REVIEW
Ke Peng, Zahra Moussavi, Keerthana Deepti Karunakaran, David Borsook, Frédéric Lesage, Dang Khoa Nguyen
Immersive virtual reality (iVR) employs head-mounted displays or cave-like environments to create a sensory-rich virtual experience that simulates the physical presence of a user in a digital space. The technology holds immense promise in neuroscience research and therapy. In particular, virtual reality (VR) technologies facilitate the development of diverse tasks and scenarios closely mirroring real-life situations to stimulate the brain within a controlled and secure setting. It also offers a cost-effective solution in providing a similar sense of interaction to users when conventional stimulation methods are limited or unfeasible...
April 2024: Neurophotonics
https://read.qxmd.com/read/38577203/gut-microbiome-in-alcohol-use-disorder-implications-for-health-outcomes-and-therapeutic-strategies-a-literature-review
#28
REVIEW
Ilias Koutromanos, Evangelia Legaki, Maria Gazouli, Efthimios Vasilopoulos, Anastasios Kouzoupis, Elias Tzavellas
Alcohol use disorder (AUD) represents a major public health issue which affects millions of people globally and consist a chronic relapsing condition associated with substantial morbidity and mortality. The gut microbiome plays a crucial role in maintaining overall health and has emerged as a significant contributor to the pathophysiology of various psychiatric disorders. Recent evidence suggests that the gut microbiome is intimately linked to the development and progression of AUD, with alcohol consumption directly impacting its composition and function...
March 20, 2024: World Journal of Methodology
https://read.qxmd.com/read/38572653/treating-neuropathic-pain-and-comorbid-affective-disorders-preclinical-and-clinical-evidence
#29
REVIEW
David Richer Araujo Coelho, Maia Gersten, Alma Sanchez Jimenez, Felipe Fregni, Paolo Cassano, Willians Fernando Vieira
INTRODUCTION: Neuropathic pain (NP) significantly impacts quality of life and often coexists with affective disorders such as anxiety and depression. Addressing both NP and its psychiatric manifestations requires a comprehensive understanding of therapeutic options. This study aimed to review the main pharmacological and non-pharmacological treatments for NP and comorbid affective disorders to describe their mechanisms of action and how they are commonly used in clinical practice. METHODS: A review was conducted across five electronic databases, focusing on pharmacological and non-pharmacological treatments for NP and its associated affective disorders...
April 4, 2024: Pain Practice: the Official Journal of World Institute of Pain
https://read.qxmd.com/read/38571884/the-relationship-between-game-genre-monetization-strategy-and-symptoms-of-gaming-disorder-in-a-clinical-sample-of-adolescents
#30
JOURNAL ARTICLE
Frida André, Per Bore, Theo Toresson, Mitchell Andersson, Emma Claesdotter-Knutsson
BACKGROUND: Gaming disorder (GD) has been introduced as a new diagnosis in the International Classification of Disease 11 (ICD-11). Currently, there's limited understanding of how various video games may differentially contribute to the risk of developing GD. The main aim of this study was to examine the relationship between individuals' game genre preferences, their preferred games' monetization strategies, and GD Symptoms. METHODS: A total of 85 patients undergoing treatment for GD at a child and youth psychiatric clinic were included in the study...
2024: Upsala Journal of Medical Sciences
https://read.qxmd.com/read/38570587/fairness-and-bias-correction-in-machine-learning-for-depression-prediction-across-four-study-populations
#31
JOURNAL ARTICLE
Vien Ngoc Dang, Anna Cascarano, Rosa H Mulder, Charlotte Cecil, Maria A Zuluaga, Jerónimo Hernández-González, Karim Lekadir
A significant level of stigma and inequality exists in mental healthcare, especially in under-served populations. Inequalities are reflected in the data collected for scientific purposes. When not properly accounted for, machine learning (ML) models learned from data can reinforce these structural inequalities or biases. Here, we present a systematic study of bias in ML models designed to predict depression in four different case studies covering different countries and populations. We find that standard ML approaches regularly present biased behaviors...
April 3, 2024: Scientific Reports
https://read.qxmd.com/read/38570074/characterisation-of-behaviours-relevant-to-apathy-syndrome-in-the-aged-male-rat
#32
JOURNAL ARTICLE
Megan G Jackson, Stafford L Lightman, Emma S J Robinson
Apathy is a complex psychiatric syndrome characterised by motivational deficit, emotional blunting and cognitive changes. It occurs alongside a broad range of neurological disorders, but also occurs in otherwise healthy ageing. Despite its clinical prevalence, apathy does not yet have a designated treatment strategy. Generation of a translational animal model of apathy syndrome would facilitate the development of novel treatments. Given the multidimensional nature of apathy, a model cannot be achieved with a single behavioural test...
April 1, 2024: Behavioural Brain Research
https://read.qxmd.com/read/38569980/bpi-gnn-interpretable-brain-network-based-psychiatric-diagnosis-and-subtyping
#33
JOURNAL ARTICLE
Kaizhong Zheng, Shujian Yu, Liangjun Chen, Lujuan Dang, Badong Chen
Converging evidence increasingly suggests that psychiatric disorders, such as major depressive disorder (MDD) and autism spectrum disorder (ASD), are not unitary diseases, but rather heterogeneous syndromes that involve diverse, co-occurring symptoms and divergent responses to treatment. This clinical heterogeneity has hindered the progress of precision diagnosis and treatment effectiveness in psychiatric disorders. In this study, we propose BPI-GNN, a new interpretable graph neural network (GNN) framework for analyzing functional magnetic resonance images (fMRI), by leveraging the famed prototype learning...
April 1, 2024: NeuroImage
https://read.qxmd.com/read/38568615/a-dynamical-systems-view-of-psychiatric-disorders-theory-a-review
#34
JOURNAL ARTICLE
Marten Scheffer, Claudi L Bockting, Denny Borsboom, Roshan Cools, Clara Delecroix, Jessica A Hartmann, Kenneth S Kendler, Ingrid van de Leemput, Han L J van der Maas, Egbert van Nes, Mark Mattson, Pat D McGorry, Barnaby Nelson
IMPORTANCE: Psychiatric disorders may come and go with symptoms changing over a lifetime. This suggests the need for a paradigm shift in diagnosis and treatment. Here we present a fresh look inspired by dynamical systems theory. This theory is used widely to explain tipping points, cycles, and chaos in complex systems ranging from the climate to ecosystems. OBSERVATIONS: In the dynamical systems view, we propose the healthy state has a basin of attraction representing its resilience, while disorders are alternative attractors in which the system can become trapped...
April 3, 2024: JAMA Psychiatry
https://read.qxmd.com/read/38568596/male-sex-and-hazardous-alcohol-use-following-military-sexual-assault-increase-suicide-risk-among-us-service-members-and-veterans
#35
JOURNAL ARTICLE
Rebecca K Blais, Bingyu Xu, Hallie Tannahill, Patrick Dulin
Background: Higher alcohol use and military sexual assault (MSA) are associated with increased risk of death by suicide. Risk for death by suicide is rapidly increasing among females, who report higher rates of MSA, yet actual death by suicide and alcohol use are higher among males. It is not well understood whether higher alcohol use confers greater suicide risk in male or female service members and veterans who have experienced MSA. Objective: To determine whether the association between alcohol misuse and suicide risk was moderated by biological sex in a sample of male and female service members ( N  = 400, 50% female) who reported MSA...
2024: European Journal of Psychotraumatology
https://read.qxmd.com/read/38563502/delineating-mechanisms-underlying-parvalbumin-neuron-impairment-in-different-neurological-and-neurodegenerative-disorders-the-emerging-role-of-mitochondrial-dysfunction
#36
JOURNAL ARTICLE
Elizaveta A Olkhova, Laura A Smith, Bethany H Dennis, Yi Shiau Ng, Fiona E N LeBeau, Gráinne S Gorman
Given the current paucity of effective treatments in many neurological disorders, delineating pathophysiological mechanisms among the major psychiatric and neurodegenerative diseases may fuel the development of novel, potent treatments that target shared pathways. Recent evidence suggests that various pathological processes, including bioenergetic failure in mitochondria, can perturb the function of fast-spiking, parvalbumin-positive neurons (PV+). These inhibitory neurons critically influence local circuit regulation, the generation of neuronal network oscillations and complex brain functioning...
April 2, 2024: Biochemical Society Transactions
https://read.qxmd.com/read/38561866/dietary-fasting-and-time-restricted-eating-in-huntington-s-disease-therapeutic-potential-and-underlying-mechanisms
#37
REVIEW
Russell G Wells, Lee E Neilson, Andrew W McHill, Amie L Hiller
Huntington's disease (HD) is a devastating neurodegenerative disorder caused by aggregation of the mutant huntingtin (mHTT) protein, resulting from a CAG repeat expansion in the huntingtin gene HTT. HD is characterized by a variety of debilitating symptoms including involuntary movements, cognitive impairment, and psychiatric disturbances. Despite considerable efforts, effective disease-modifying treatments for HD remain elusive, necessitating exploration of novel therapeutic approaches, including lifestyle modifications that could delay symptom onset and disease progression...
April 2, 2024: Translational Neurodegeneration
https://read.qxmd.com/read/38560047/theta-frequency-medial-septal-nucleus-deep-brain-stimulation-increases-neurovascular-activity-in-mk-801-treated-mice
#38
JOURNAL ARTICLE
Lindsey M Crown, Kofi A Agyeman, Wooseong Choi, Nancy Zepeda, Ege Iseri, Pooyan Pahlavan, Steven J Siegel, Charles Liu, Vasileios Christopoulos, Darrin J Lee
INTRODUCTION: Deep brain stimulation (DBS) has shown remarkable success treating neurological and psychiatric disorders including Parkinson's disease, essential tremor, dystonia, epilepsy, and obsessive-compulsive disorder. DBS is now being explored to improve cognitive and functional outcomes in other psychiatric conditions, such as those characterized by reduced N-methyl-D-aspartate (NMDA) function (i.e., schizophrenia). While DBS for movement disorders generally involves high-frequency (>100 Hz) stimulation, there is evidence that low-frequency stimulation may have beneficial and persisting effects when applied to cognitive brain networks...
2024: Frontiers in Neuroscience
https://read.qxmd.com/read/38559781/lifestyle-coaching-may-be-an-effective-treatment-for-schizophrenia
#39
REVIEW
Jacob Daniel Kanofsky, Shankar Viswanathan, Judith Wylie-Rosett
This commentary critiques the Danish CHANGE trial, which evaluated 3 levels of outpatient intervention intensity, in a group of outpatients with obesity and schizophrenia. Neither adding care coordination with weekly nurse contacts alone nor combining this treatment with assertive community lifestyle coaching as compared to treatment as usual improved outcomes, which included cardiovascular disease risk calculation, cardiorespiratory fitness, weight, and self-reported behaviors such as smoking, physical activity, and diet...
2024: American Journal of Lifestyle Medicine
https://read.qxmd.com/read/38558976/unlocking-the-potential-of-high-quality-dopamine-transporter-pharmacological-data-advancing-robust-machine-learning-based-qsar-modeling
#40
Kuo Hao Lee, Sung Joon Won, Precious Oyinloye, Lei Shi
The dopamine transporter (DAT) plays a critical role in the central nervous system and has been implicated in numerous psychiatric disorders. The ligand-based approaches are instrumental to decipher the structure-activity relationship (SAR) of DAT ligands, especially the quantitative SAR (QSAR) modeling. By gathering and analyzing data from literature and databases, we systematically assemble a diverse range of ligands binding to DAT, aiming to discern the general features of DAT ligands and uncover the chemical space for potential novel DAT ligand scaffolds...
March 11, 2024: bioRxiv
keyword
keyword
88061
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.